DEEPNOID Inc.
Financials
Valuation Metrics
DEEPNOID Inc.'s Market Cap is ₩563B. At end of 2025 it was ₩953B. Ranked #1699 of 2,421 in KR market (top 70%), #1026 of 1,640 on KOSDAQ (top 63%), #67 of 96 in Health Care Equipment & Services (top 70%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 56.28B KRW | KR#1,699/2,421 Sec#67/96 |
| Revenue | 4.51B KRW | KR#2,346/2,421 Sec#90/96 |
| Net Income | -14.32B KRW | KR—/2,421 Sec—/96 |
| Total Assets | 32.58B KRW | KR#2,320/2,421 Sec#86/96 |
| Net Assets | 21.37B KRW | KR#2,271/2,421 Sec#84/96 |
| Employees | 170 | KR#1,219/2,421 Sec#38/96 |
| Value | ||
| P/B | 2.63x | KR#2,061/2,421 Sec#76/96 |
| P/S | 12.49x | KR#2,297/2,421 Sec#86/96 |
| FCF Yield | -12.86% | KR—/2,421 Sec—/96 |
| Profitability | ||
| ROE | -67.02% | KR#2,315/2,421 Sec#89/96 |
| ROA | -43.96% | KR#2,355/2,421 Sec#92/96 |
| Op. Margin | -311.32% | KR#2,351/2,421 Sec#90/96 |
| Revenue Growth | -59.93% | KR#2,304/2,421 Sec#92/96 |
| Financial Health | ||
| Debt Ratio | 52.47% | KR#991/2,421 Sec#57/96 |
| Total Debt | 6.66B KRW | KR#1,736/2,421 Sec#59/96 |
| FCF | -7.24B KRW | KR#1,607/2,421 Sec#57/96 |
| Cash | 4.45B KRW | KR#2,048/2,421 Sec#76/96 |
| Current Ratio | 11.26x | KR#83/2,421 Sec#10/96 |
| Performance | ||
| 1Y Return | -58.62% | KR#2,186/2,421 Sec#80/96 |
| 1M Return | 16.55% | KR#299/2,421 Sec#9/96 |
| From 52W High | -62.76% | KR#1,958/2,421 Sec#68/96 |
| 1Y MDD | -75.76% | KR#2,206/2,421 Sec#86/96 |
| Trading | ||
| Volume | 546,720 shares | KR#214/2,421 Sec#4/96 |
| Trading Value | 1.09B KRW | KR#695/2,421 Sec#19/96 |
| Foreign Own. | 2.88% | KR#1,325/2,421 Sec#46/96 |
| Per Share | ||
| EPS | -488 KRW | KR—/2,421 Sec—/96 |
| BPS | 728 KRW | KR#2,354/2,421 Sec#90/96 |
Company Info
DEEPNID, an artificial intelligence company established in 2008, listed on KOSDAQ in 2021 under special provisions for technology growth companies. The company operates businesses providing AI solutions for medical diagnosis and interpretation assistance, early disease diagnosis, X-Ray image automatic interpretation, and deep learning-based vision inspection. Leveraging its medical imaging AI technology, DEEPNID is accelerating market entry through the development of generative AI medical solutions and collaboration with the global leader in machine vision market share. DEEPNID is headquartered in Guro-gu, Seoul.